CORZW Core Scientific, Inc./tx
Finance Services · Nasdaq · SEC CIK 1839341 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY77.2%
TTM net income YoY86.1%
TTM EPS YoY-650.0%
Revenue 3-yr CAGR7.1%
Net income 3-yr CAGR—
Margins
Gross margin41.2%
Operating margin-73.6%
Net margin-18.6%
FCF margin-223.0%
EBITDA margin-62.8%
Returns
ROE—
ROA-2.7%
ROIC (approx.)-98.4%
Asset turnover0.15x
Leverage & solvency
Liabilities / assets118.4%
Debt / equity—
Current ratio0.67x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-4.08x
Accruals ratio-13.8%
Payout ratio—
Capex / revenue298.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $319.02M | $510.67M | $502.40M | $640.31M | $544.48M |
| Cost of revenue | $281.12M | $389.60M | $378.94M | $631.91M | $305.62M |
| Gross profit | $37.90M | $121.07M | $123.46M | $8.40M | $238.86M |
| R&D expense | — | $11.83M | $7.18M | $26.96M | $7.67M |
| SG&A expense | $159.22M | $113.69M | $108.11M | $213.28M | $60.49M |
| Operating income | -$245.59M | -$142.06M | $8.96M | -$2.11B | $131.49M |
| Pretax income | -$288.03M | -$1.44B | -$245.80M | -$2.16B | $63.08M |
| Income tax | $583,000 | $859,000 | $683,000 | -$17.09M | $15.76M |
| Net income | -$288.62M | -$1.44B | -$246.49M | -$2.15B | $47.31M |
| EBITDA | -$176.68M | -$28.86M | $104.96M | -$1.88B | $164.86M |
| EPS (basic) | -0.88 | -4.87 | -0.65 | -6.30 | 0.23 |
| EPS (diluted) | -0.88 | -4.87 | -0.65 | -6.30 | 0.20 |
| Weighted avg. shares (diluted) | 318.07M | 255.83M | 379.86M | 340.65M | 233.31M |
| Balance sheet | |||||
| Cash & equivalents | $311.38M | $836.98M | $50.41M | $52.24M | $131.68M |
| Receivables | — | $1.02M | $1.00M | $234,000 | $1.38M |
| Current assets | $895.54M | $903.96M | $97.02M | $85.10M | $756.56M |
| PP&E, net | $1.29B | $433.47M | $585.43M | $691.13M | $597.30M |
| Goodwill | — | — | $0 | $0 | $1.06B |
| Intangibles | $1.08M | — | $2.25M | $1.70M | $8.20M |
| Total assets | $2.35B | $1.48B | $712.16M | $807.69M | $2.44B |
| Current liabilities | $781.40M | $134.56M | $488.42M | $186.79M | $320.29M |
| Short-term debt | $0 | — | — | — | — |
| Long-term debt | $1.06B | — | — | — | — |
| Total debt | $1.06B | — | — | — | — |
| Total liabilities | $3.31B | $2.42B | $1.31B | $1.22B | $1.05B |
| Shareholders' equity | -$962.74M | -$943.05M | -$596.94M | -$409.35M | $1.34B |
| Net debt | $748.95M | — | — | — | — |
| Shares outstanding | 314.23M | 292.61M | 386.88M | 375.23M | 271.58M |
| Cash flow statement | |||||
| Operating cash flow | $278.25M | $42.90M | $65.11M | $205.19M | -$56.73M |
| Capital expenditure | $729.00M | $94.96M | $16.16M | $383.98M | $0 |
| Free cash flow | -$450.75M | -$52.06M | $48.95M | -$178.79M | -$56.73M |
| Investing cash flow | -$740.75M | -$95.19M | -$3.00M | -$590.78M | -$423.84M |
| Financing cash flow | -$63.10M | $819.57M | -$44.65M | $306.15M | $603.53M |
| Depreciation & amortization | $68.91M | $113.20M | $96.00M | $225.26M | $33.36M |
| Stock-based compensation | $98.24M | $51.92M | $58.89M | $182.89M | $38.94M |
| Share buybacks | — | $0 | $0 | $31.65M | — |
Free plan shows the latest 5 periods; Pro shows all 6 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.